
GLOW70 mg Blend
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
GLOW, explained simply
A blend of GHK-Cu, TB-500, and BPC-157, compounds individually associated with different aspects of tissue remodelling research.
Research area
Skin, extracellular matrix and tissue repair
How it works
Research links GHK-Cu to collagen and skin signalling, TB-500 to cell migration and BPC-157 to preclinical repair models.
Why it matters
The profile brings distinct mechanisms together while keeping evidence for each component separate from evidence for the blend.
What has been observed
Research on the components does not demonstrate a combined effect of the blend in humans.
Effects and points to consider
Composition, formulation and strength of evidence need to be considered for each ingredient. A result for one peptide does not validate the mixture.
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Total vial mass | 70 mg |
|---|---|
| Component masses | GHK-Cu: 50 mg; BPC-157: 10 mg; TB-500: 10 mg |
| Final volume | 3 mL |
| Concentration | 23.33 mg/mL |
| Frequency | once daily |
| Cycle | 4 in table |
Standard Approach (3 mL = 23.3 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–4 | 2,330 mcg | 10 units (0.10 mL) |
Supplies needed


Sterile alcohol swabs
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.